Financhill
Sell
42

NKTR Quote, Financials, Valuation and Earnings

Last price:
$0.64
Seasonality move :
-2.55%
Day range:
$0.60 - $0.66
52-week range:
$0.43 - $1.93
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.33x
P/B ratio:
1.95x
Volume:
2M
Avg. volume:
2.3M
1-year change:
-52.86%
Market cap:
$118.4M
Revenue:
$98.4M
EPS (TTM):
-$0.59

Nektar Therapeutics SEC Filings

Company Filed Form Type Description
NKTR
Nektar Therapeutics
05/10/2024 10-Q 10-Q filing on 05/10/2024 View Form
NKTR
Nektar Therapeutics
11/08/2023 10-Q 10-Q filing on 11/08/2023 View Form
NKTR
Nektar Therapeutics
08/09/2023 10-Q 10-Q filing on 08/09/2023 View Form
NKTR
Nektar Therapeutics
05/10/2023 10-Q 10-Q filing on 05/10/2023 View Form
NKTR
Nektar Therapeutics
11/04/2022 10-Q 10-Q filing on 11/04/2022 View Form
NKTR
Nektar Therapeutics
08/05/2022 10-Q 10-Q filing on 08/05/2022 View Form
NKTR
Nektar Therapeutics
05/06/2022 10-Q 10-Q filing on 05/06/2022 View Form
NKTR
Nektar Therapeutics
11/05/2021 10-Q 10-Q filing on 11/05/2021 View Form
NKTR
Nektar Therapeutics
08/06/2021 10-Q 10-Q filing on 08/06/2021 View Form
NKTR
Nektar Therapeutics
05/07/2021 10-Q 10-Q filing on 05/07/2021 View Form
NKTR
Nektar Therapeutics
11/06/2020 10-Q 10-Q filing on 11/06/2020 View Form
NKTR
Nektar Therapeutics
08/07/2020 10-Q 10-Q filing on 08/07/2020 View Form
NKTR
Nektar Therapeutics
05/08/2020 10-Q 10-Q filing on 05/08/2020 View Form
NKTR
Nektar Therapeutics
02/28/2020 10-K 10-K filing on 02/28/2020 View Form
NKTR
Nektar Therapeutics
11/07/2019 10-Q 10-Q filing on 11/07/2019 View Form
NKTR
Nektar Therapeutics
08/09/2019 10-Q 10-Q filing on 08/09/2019 View Form
NKTR
Nektar Therapeutics
05/09/2019 10-Q 10-Q filing on 05/09/2019 View Form
NKTR
Nektar Therapeutics
03/01/2019 10-K 10-K filing on 03/01/2019 View Form
NKTR
Nektar Therapeutics
11/08/2018 10-Q 10-Q filing on 11/08/2018 View Form
NKTR
Nektar Therapeutics
08/09/2018 10-Q 10-Q filing on 08/09/2018 View Form
NKTR
Nektar Therapeutics
05/10/2018 10-Q 10-Q filing on 05/10/2018 View Form
NKTR
Nektar Therapeutics
03/01/2018 10-K 10-K filing on 03/01/2018 View Form
NKTR
Nektar Therapeutics
11/08/2017 10-Q 10-Q filing on 11/08/2017 View Form
NKTR
Nektar Therapeutics
08/09/2017 10-Q 10-Q filing on 08/09/2017 View Form
NKTR
Nektar Therapeutics
05/10/2017 10-Q 10-Q filing on 05/10/2017 View Form
NKTR
Nektar Therapeutics
03/01/2017 10-K 10-K filing on 03/01/2017 View Form
NKTR
Nektar Therapeutics
11/04/2016 10-Q 10-Q filing on 11/04/2016 View Form
NKTR
Nektar Therapeutics
08/04/2016 10-Q 10-Q filing on 08/04/2016 View Form
NKTR
Nektar Therapeutics
05/04/2016 10-Q 10-Q filing on 05/04/2016 View Form
NKTR
Nektar Therapeutics
02/29/2016 10-K 10-K filing on 02/29/2016 View Form
NKTR
Nektar Therapeutics
11/06/2015 10-Q 10-Q filing on 11/06/2015 View Form
NKTR
Nektar Therapeutics
08/06/2015 10-Q 10-Q filing on 08/06/2015 View Form
NKTR
Nektar Therapeutics
05/01/2015 10-Q 10-Q filing on 05/01/2015 View Form
NKTR
Nektar Therapeutics
04/30/2015 10-K 10-K filing on 04/30/2015 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Uber Stock a Buy, Sell or Hold?
Is Uber Stock a Buy, Sell or Hold?

Uber (NYSE:UBER) has been through quite a ride over the…

Is Micron a Good Stock to Buy Now?
Is Micron a Good Stock to Buy Now?

Like most of its peers in the semiconductor industry, Micron…

Is Uber Finally on the Path to Consistent Profitability?
Is Uber Finally on the Path to Consistent Profitability?

After posting massive losses quarter after quarter for years, Uber…

Stock Ideas

Sell
50
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 32x

Sell
47
Is MSFT Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 31x

Sell
46
Is NVDA Stock a Buy?

Market Cap: $2.5T
P/E Ratio: 35x

Alerts

Sell
32
MAN alert for Apr 18

ManpowerGroup [MAN] is down 19.07% over the past day.

Sell
24
GPN alert for Apr 18

Global Payments [GPN] is down 17.44% over the past day.

Buy
51
CAR alert for Apr 18

Avis Budget Group [CAR] is up 16.54% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock